Orthofix International NV (OFIX)

Orthofix International N.V. designs, develops, manufactures, markets, and distributes medical equipment, principally for the orthopedic applications. The company’s products include invasive and minimally invasive spinal implant products and related human cellular and tissue based products; non-invasive stimulation products for spinal fusions and to treat non-union fractures; external and internal fixation devices used in fracture treatment, limb lengthening, and bone reconstruction; and bracing products used for ligament injury prevention, pain management, and protection of surgical repair. It also offers device for enhancing venous circulation; cold therapy and other pain management products; bone cement and devices for removal of bone cement used to fix artificial implants; and airway management products used in anesthesia applications. The company provides its products for the spine, orthopedics, sports medicine, and vascular market sectors serving hospitals, clinics, surgery centers, independent distributors or other healthcare providers, and patients by third-party payors. It distributes its products in the United States, the United Kingdom, Italy, Germany, Switzerland, Austria, France, Belgium, Mexico, Brazil, and Puerto Rico through its direct sales representatives and independent distributors. The company was founded in 1979 and is based in Curacao, the Netherlands Antilles.

For the nine months ended 30 September 2006, Othofix International NV's revenues increased 7% to $249.2M. Net loss totaled $14.4M vs. an income of $66.2M. Revenues reflect an increase in sales from Spine market due to higher demand for Limbar & Cervical-Stimulation products. Net loss reflects higher sales & marketing expense, increased research & development expense and higher general & administrative expense.